Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85,086 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Can nirmatrelvir/ritonavir treatment shorten the duration of COVID-19 isolation?
Kim H, Yang JS, Ko JH, Lee M, Lee JY, Park S, Kim JW, Shin Y, Lee JM, Na YJ, Park BK, Kim H, Lee YH, Yang J, Huh K, Cho SY, Kang CI, Chung DR, Peck KR. Kim H, et al. Among authors: yang js, yang j. Front Med (Lausanne). 2022 Oct 12;9:988559. doi: 10.3389/fmed.2022.988559. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36314031 Free PMC article.
Augmented humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 after breakthrough infection in kidney transplant recipients who received 3 doses of coronavirus disease 2019 vaccine.
Yang J, Lee KW, Baek JY, Bae S, Lee YH, Kim H, Huh K, Cho SY, Kang CI, Chung DR, Peck KR, Park JB, Kim SH, Kim TJ, Kim DM, Ko JH. Yang J, et al. Am J Transplant. 2023 Apr;23(4):565-572. doi: 10.1016/j.ajt.2022.12.022. Epub 2023 Jan 3. Am J Transplant. 2023. PMID: 36739177 Free PMC article.
Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections.
Yang J, Won G, Baek JY, Lee YH, Kim H, Huh K, Cho SY, Kang CI, Chung DR, Peck KR, Lee KW, Park JB, Yoon SE, Kim SJ, Kim WS, Yim MS, Kim K, Hyeon S, Kim BC, Lee YK, Ko JH. Yang J, et al. Front Immunol. 2023 Mar 2;14:1139980. doi: 10.3389/fimmu.2023.1139980. eCollection 2023. Front Immunol. 2023. PMID: 36936968 Free PMC article.
Loss of Neutralizing Activity of Tixagevimab/Cilgavimab (Evusheld™) Against Omicron BN.1, a Dominant Circulating Strain Following BA.5 During the Seventh Domestic Outbreak in Korea in Early 2023.
Yang J, Hyeon S, Baek JY, Kang MS, Lee KY, Lee YH, Huh K, Cho SY, Kang CI, Chung DR, Peck KR, Won G, Lee HW, Kim K, Hwang I, Lee SY, Kim BC, Lee YK, Ko JH. Yang J, et al. J Korean Med Sci. 2023 Jul 10;38(27):e205. doi: 10.3346/jkms.2023.38.e205. J Korean Med Sci. 2023. PMID: 37431539 Free PMC article.
Clinical Characteristics and Risk Factors for Mortality in Critical COVID-19 Patients Aged 50 Years or Younger During Omicron Wave in Korea: Comparison With Patients Older Than 50 Years of Age.
Shi HJ, Yang J, Eom JS, Ko JH, Peck KR, Kim UJ, Jung SI, Kim S, Seok H, Hyun M, Kim HA, Kim B, Joo EJ, Cheong HS, Jun CH, Wi YM, Kim J, Kym S, Lim S, Park Y. Shi HJ, et al. Among authors: yang j. J Korean Med Sci. 2023 Jul 17;38(28):e217. doi: 10.3346/jkms.2023.38.e217. J Korean Med Sci. 2023. PMID: 37463688 Free PMC article.
Longitudinal kinetics of neutralizing antibodies against circulating SARS-CoV-2 variants and estimated level of group immunity of booster-vaccinated individuals during omicron-dominated COVID-19 outbreaks in the Republic of Korea, 2022.
Lee YJ, Choi JY, Yang J, Baek JY, Kim HJ, Kim SH, Jeong H, Kim MS, Lee HW, Kang G, Chung EJ, Kim TY, Hong HJ, Lee SE, Jang YG, Kim SS, Peck KR, Ko JH, Kim B. Lee YJ, et al. Among authors: yang j. Microbiol Spectr. 2023 Sep 26;11(5):e0165523. doi: 10.1128/spectrum.01655-23. Online ahead of print. Microbiol Spectr. 2023. PMID: 37750684 Free PMC article.
85,086 results
You have reached the last available page of results. Please see the User Guide for more information.